Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Cecilia Ysabel Arana Yi"'
Autor:
Ahmad Nanaa, Hassan B. Alkhateeb, Talha Badar, James M. Foran, Lisa Ostrosky Sproat, Cecilia Ysabel Arana Yi, Phuong L. Nguyen, Dragan Jevremovic, Patricia T. Greipp, Naseema Gangat, Ayalew Tefferi, Mark Robert Litzow, Mithun Vinod Shah, Abhishek Avinash Mangaonkar, Mrinal Patnaik, David Viswanatha, Rong He, Aref Al-Kali
Publikováno v:
Journal of Clinical Oncology. 40:e19010-e19010
e19010 Background: Mutated DEAD-box helicase 41 (m DDX41), and mutated GATA2 are germline mutations associated with familial predisposition syndromes. In this study, we compare the clinical characteristics and survival outcomes (OS) of m DDX41 and m
Autor:
Bahga Katamesh, Ahmad Nanaa, Rong He, David Viswanatha, Phuong L. Nguyen, Patricia T. Greipp, Naseema Gangat, Kebede Begna, Abhishek Avinash Mangaonkar, Mrinal Patnaik, William J. Hogan, Mark Robert Litzow, Mithun Vinod Shah, Cecilia Ysabel Arana Yi, James M. Foran, Talha Badar, Hassan B. Alkhateeb, Aref Al-Kali
Publikováno v:
Journal of Clinical Oncology. 40:e19014-e19014
e19014 Background: Stromal Antigen 2 ( STAG2), located on Xq25, is the most mutated (m) cohesin-complex gene in myeloid neoplasm (MN) patients (pts). mSTAG2 is present in around 5% of MN and has been linked to secondary AML and potential poor impact
Autor:
Abhishek Avinash Mangaonkar, Cecilia Ysabel Arana Yi, Hemant S. Murthy, Talha Badar, James M. Foran, Susan Michelle Geyer, Kristen Beth McCullough, Erinayo S Baba Lola, Jean Hanson, Aref Al-Kali, Hassan B. Alkhateeb, Mithun Vinod Shah, Kebede Begna, Michelle A. Elliott, Naseema Gangat, Mark Robert Litzow, Alexandra P. Wolanskyj-Spinner, William J. Hogan, Ayalew Tefferi, Mrinal Patnaik
Publikováno v:
Journal of Clinical Oncology. 40:TPS7080-TPS7080
TPS7080 Background: Myelodysplastic syndrome/myeloproliferative neoplasms (MDS/MPN) are classified as a distinct category under the World Health Organization (WHO) classification of myeloid neoplasms. MDS/MPN with RS and thrombocytosis (MDS/MPN-RS-T)
Autor:
Guru Subramanian Guru Murthy, Tyce Kearl, Weigo Cui, Bryon Johnson, Karin Hoffmeister, Alexandra Harrington, Aniko Szabo, Talha Badar, Adam Duvall, Jessica Taft Leonard, Cecilia Ysabel Arana Yi, Arielle Baim, Shahriar Yaghoubi, Bijal D. Shah, Wendy Stock, Ehab L. Atallah
Publikováno v:
Journal of Clinical Oncology. 40:TPS7070-TPS7070
TPS7070 Background: Outcomes of adults with relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) and acute myeloid leukemia (AML) have remained poor. CD38 is a transmembrane glycoprotein with several important functions including its role
Autor:
Pedro P. Medina, Sherry Pierce, Cecilia Ysabel Arana Yi, Mark Brandt, Srdan Verstovsek, Ghayathri Jeyakumar, Hagop M. Kantarjian, Jorge E. Cortes
Publikováno v:
Journal of Clinical Oncology. 31:7115-7115
7115 Background: Primary Myelofibrosis (PMF) is a stem cell-derived clonal disorder with broad disease spectrum and the diagnosis is based on a combination of clinicopathological criteria. The aim of the study is to evaluate the frequency of diagnost
Autor:
Tapan M. Kadia, Andrew Coveler, Peter F. Thall, Stefan Faderl, John Gutheil, Naval Daver, William R. Wilson, Hagop M. Kantarjian, Marina Konopleva, Elias Jabbour, Steven M. Kornblau, Jorge E. Cortes, Naveen Pemmaraju, Hoang Q. Nguyen, Elihu H. Estey, Cecilia Ysabel Arana Yi, Deborah A. Thomas, Farhad Ravandi, Teresa J. Melink, Gautam Borthakur
Publikováno v:
Journal of Clinical Oncology. 31:7074-7074
7074 Background: Hypoxia is prevalent in leukemia bone marrow (BM) microenvironment, suggesting its role as a therapeutic target. PR104 is a pro-drug activated by hypoxia-dependent reductases and by hypoxia-independent aldo-ketoreductase 1C3 (AKR1C3)
Autor:
Hagop M. Kantarjian, Guillermo Garcia-Manero, Jorge E. Cortes, Wei Qiao, Gautam Borthakur, Cecilia Ysabel Arana Yi, Tapan M. Kadia, Farhad Ravandi, Stefan Faderl, Mark Brandt
Publikováno v:
Journal of Clinical Oncology. 31:7089-7089
7089 Background: Trisomy 8 is grouped as intermediate risk in cytogenetic (CG) classifications of acute myelogenous leukemia (AML). In a multi-variate analysis of MRC data, trisomy 8 was associated with worse overall survival (OS). Methods: Between y